Synopsis Its consolidated revenue from operations stood at Rs 2,859.9 crore for the quarter under consideration. It was Rs 2,767.5 crore for the same period a year ago. Related REC Q4 results: Co reports multifold jump in net profit at Rs 2,077 crore City Union Bank Q4 results: Lender reports net profit at Rs 111 crore Deepak Fertilisers FY21 results: Net profit jumps 357% to Rs 406 crore NEW DELHI: Drug firm Glenmark Pharmaceuticals has reported a 6.15 per cent rise in its consolidated net profit to Rs 233.87 crore for the quarter ended March 2021 on account of higher sales. The company had posted a net profit of Rs 220.30 crore in the corresponding period of the previous fiscal, Glenmark said in a late regulatory filing on Friday. Its consolidated revenue from operations stood at Rs 2,859.9 crore for the quarter under consideration. It was Rs 2,767.5 crore for the same period a year ago, it added. Stock Score, Analysts’ Ratings & Recommendations EARNINGS FUNDAMENTAL RELATIVE VALUATION RISK PRICE MOMENTUM Stock score of Glenmark Pharmaceuticals Ltd moved down by 1 in a month on a 10-point scale. View Latest Stock Report Stock Analysis Stock score of Glenmark Pharmaceuticals Ltd… Read full this story
- UHS sees net income, revenue gains in Q1
- Update: Cisco posts record profit in Q4
- Update: HP server group sees profit in Q4
- Microsoft tops Q4 estimates
- IBM warns Q1 profit may drop
- McAfee.com rides the virus wave
- Seasonal goodwill? The e-Christmas verdict
- SAP's sales loss larger than expected
- How blockchain will disrupt Google, Apple, Amazon, and Facebook
- Cisco earnings fall, but don't disappoint
Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr have 250 words, post on economictimes.indiatimes.com at May 29, 2021. This is cached page on Vietnam Colors. If you want remove this page, please contact us.